Pharmafile Logo
Pharmafocus logo
Advanced Search
vaccination-1215279_960_720

BioNTech’s melanoma vaccine shows promise in early interim analysis

July 30, 2020
Research and Development BioNTech, Cancer, pharma

While the company has more recently drawn headlines for its COVID-19 efforts, BioNTech has unveiled promising interim Phase 1 data …

News

NICE shoots down Kyowa Kirin’s Poteligeo for NHS treatment of mycosis fungoides or Sézary syndrome

July 30, 2020
Sales and Marketing Kyowa Kirin, NICE, pharma

NICE has issued draft guidance that has shot down Kyowa Kirin’s therapy Poteligeo (mogamulizumab) for use on the NHS in …

News

Takeda poised to cut sales jobs in Japan as restructuring continues

July 29, 2020
Medical Communications, Research and Development, Sales and Marketing Japan, Takeda, job cuts

Japan’s biggest drug firm Takeda is said to be mulling plans to cut back its sales operations with a new …

News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

July 29, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, pharma

The once-touted COVID cure hydroxychloroquine continues its downward spiral of credibility as new data is published on its lack of …

News
novartis_outside_1

Novartis’ Piqray combo becomes first Europe-approved therapy for PIK3CA-mutated advanced breast cancer

July 29, 2020
Research and Development, Sales and Marketing Europe, Novartis, Piqray, breast cancer, pharma

The European Commission (EC) has awarded its approval for Novartis’ Piqray (alpelisib) to be made available in combination with fulvestrant …

News
shutterstock_359806121

UK Government secures 60 million doses of Sanofi and GSK’s COVID-19 vaccine

July 29, 2020
Research and Development, Sales and Marketing COVID-19, GSK, Sanofi, UK government, pharma

The UK Government has sealed another deal to procure an effective COVID-19 vaccine for its citizens, partnering up with Sanofi …

News
roche

Roche’s Actemra fails to improve clinical status in COVID-19-associated pneumonia

July 29, 2020
Research and Development Actemra, COVID-19, Roche, pharma

Roche has announced the disappointing news that its therapy Actemra/RoActemra (tocilizumab) failed to improve clinical status to a statistically significant …

News
lilly_building_with_american_flag_web

Eli Lilly teams up with Chi-Med for Chinese sales of Elunate capsules

July 28, 2020
Manufacturing and Production, Sales and Marketing Chi-Med, China, Eli Lilly

Eli Lilly Shanghai, an affiliate of the wider company, has enlisted the help of biopharma firm Hutchinson China MediTech, or …

News

Yale-backed study to test efficacy of AI-selected therapy in COVID-19

July 28, 2020
Manufacturing and Production, Research and Development AI, COVID-19, clinical trial, pharma

Biopharma firm AI Therapeutics is partnering with Yale School of Medicine to launch a new clinical trial to identify the efficacy …

News
shutterstock_159488225

Farxiga smashes all goals in Phase 3 chronic kidney disease trial, says AstraZeneca

July 28, 2020
Manufacturing and Production, Research and Development AstraZeneca, farxiga

AstraZeneca has teased new data from a Phase 3 study of its sodium-glucose co-transporter-2 (SGLT2) inhibitor Farxiga (dapagliflozin) in the …

News
shutterstock_38078521

Kyowa Kirin’s Crysvita secures CHMP support in rare X-linked hypophosphataemia

July 28, 2020
Manufacturing and Production, Sales and Marketing CHMP, EMA

The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has given its backing to Kyowa Kirin’s …

News
celltrion1

Celltrion’s infliximab biosimilar Remsima secures European approval in five indications

July 27, 2020
Manufacturing and Production, Sales and Marketing celltrion, infliximab, pharma, remsima

The subcutaneous (SC) formulation of Remsima, Celltrion’s biosimilar version of infliximab, has secured approval from the European Commission covering five …

News
shutterstock_273326141

AstraZeneca partners with Daichii Sankyo in potential $6bn cancer drug deal

July 27, 2020
Research and Development, Sales and Marketing AstraZeneca, Daiichi Sankyo, partnership, pharma

AstraZeneca and Daiichi Sankyo have joined forces to drive the development and commercialisation of the latter’s DS-1062, a trophoblast cell-surface …

News
moderna_norwood_plant

US Government invests a further $472 million in Moderna’s BARDA-backed COVID-19 vaccine

July 27, 2020
Research and Development, Sales and Marketing COVID-19, Moderna, US government, Vaccine

Moderna has revealed a second investment of $472 million from the US Government’s Biomedical Advanced Research and Development Authority (BARDA) to support …

News
biocon-k8tc--621x414livemint

India’s National Task Force rejects Biocon’s itolizumab for COVID-19

July 27, 2020
Sales and Marketing Biocon, COVID-19, India, Itolizumab

Biocon was hit with bad news over the weekend as the National Task Force for COVID-19 in its home country …

News
fdaoutsideweb

Kite secures FDA approval for second CAR T therapy Tecartus in relapsed or refractory mantle cell lymphoma

July 27, 2020
Sales and Marketing CAR T, CAR-T, FDA, Gilead, kite pharma

Kite Pharma has chalked up another regulatory success for its parent company Gilead with the news that the FDA has …

News
astrazeneca_sign_sky

Two CHMP recommendations for AstraZeneca: Imfinzi in first-line lung cancer, Calquence in chronic lymphocytic leukaemia

July 27, 2020
Sales and Marketing AstraZeneca, CHMP, Calquence, EMA, Imfinzi

AstraZeneca has secured two new recommendations for approval of its products from the European Medicines Agency’s Committee for Medicinal Products …

News
glenmark

Glenmark’s favipiravir accelerates viral clearance and clinical recovery in COVID-19 patients

July 24, 2020
Medical Communications, Research and Development COVID-19, coronavirus, favipiravir; Glenmark

The antiviral treatment favipiravir, in development from Glenmark Pharma, has shown promise as a potential COVID-19 therapy after hitting its …

News
indianapolis

Eli Lilly asks for a $24 million tax break for diabetes care facility expansion in Indianapolis

July 24, 2020
Medical Communications Eli Lilly, Humalog, diabetes, insulin

Insulin manufacturer Eli Lilly has requested a $24 million tax break over the next 10 years as an investment into …

News

UCB’s investigational IL-17A and IL-17F inhibitor outclasses Novartis’ Cosentyx in plaque psoriasis

July 24, 2020
Medical Communications, Research and Development Cosentyx, UCB, pharma, psoriasis

UCB has revealed promising new data from a head-to-head trial pitting the company’s IL-17A and IL-17F inhibitor bimekizumab against Novartis’ …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026